mucosal immunology
Recently Published Documents


TOTAL DOCUMENTS

149
(FIVE YEARS 17)

H-INDEX

20
(FIVE YEARS 2)

2022 ◽  
pp. 251-284
Author(s):  
Francisco A. Guardiola ◽  
Alberto Cuesta ◽  
María Ángeles Esteban
Keyword(s):  

Author(s):  
Hiroshi Kiyono ◽  
Yoshikazu Yuki ◽  
Rika Nakahashi-Ouchida ◽  
Kohtaro Fujihashi

Abstract The oral and nasal cavities are covered by the mucosal epithelium that starts at the beginning of the aero-digestive tract. These mucosal surfaces are continuously exposed to environmental antigens including pathogens and allergens and are thus equipped with a mucosal immune system that mediates initial recognition of pathogenicity and initiates pathogen-specific immune responses. At the dawn of our scientific effort to explore the mucosal immune system, dental science was one of the major driving forces as it provided insights into the importance of mucosal immunity and its application for the control of oral infectious diseases. The development of mucosal vaccines for the prevention of dental caries was thus part of a novel approach that contributed to building the scientific foundations of the mucosal immune system. Since then, mucosal immunology and vaccines have gone on a scientific journey to become one of the major entities within the discipline of immunology. Here, we introduce our past and current efforts and future directions for the development of mucosal vaccines, specifically a rice-based oral vaccine (MucoRice) and a nanogel-based nasal vaccine, with the aim of preventing and controlling gastrointestinal and respiratory infectious diseases using the interdisciplinary fusion of mucosal immunology with agricultural science and biomaterial engineering, respectively.


Author(s):  
Carl Weidinger ◽  
Ahmed Nabil Hegazy ◽  
Rainer Glauben ◽  
Britta Siegmund

AbstractViral infections with SARS-CoV-2 can cause a multi-facetted disease, which is not only characterized by pneumonia and overwhelming systemic inflammatory immune responses, but which can also directly affect the digestive system and infect intestinal epithelial cells. Here, we review the current understanding of intestinal tropism of SARS-CoV-2 infection, its impact on mucosal function and immunology and summarize the effect of immune-suppression in patients with inflammatory bowel disease (IBD) on disease outcome of COVID-19 and discuss IBD-relevant implications for the clinical management of SARS-CoV-2 infected individuals.


2020 ◽  
Vol 13 (3) ◽  
pp. 383-384
Author(s):  
Brian Kelsall
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document